ARTICLE | Clinical News
Rempex Pharmaceuticals preclinical data
September 17, 2012 7:00 AM UTC
In a nitrocefin degradation assay, which measures the kinetics of beta lactamase activity, RPX7009 inhibited Klebsiella pneumoniae carbapenemase-2 (KPC-2) with a Ki value of 0.071 µM, while clavulanic...